| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/07/2002 | EP1229040A2 Nucleoside monophosphate derivative, a processor for their production and their use as immunosuppressive drugs |
| 08/07/2002 | EP1229035A1 Imine intermediates for the preparation of trisubstituted imidazole compounds with multiple therapeutic properties |
| 08/07/2002 | EP1229034A1 Nicotinamide derivatives and their mimetics as inhibitors of PDE4 isozymes |
| 08/07/2002 | EP1229025A1 Novel quinazoline derivatives |
| 08/07/2002 | EP1228769A1 Symbiotic regenerative composition |
| 08/07/2002 | EP1228767A1 Use of beta-Glucuronidase for the treatment of immune or allergic diseases |
| 08/07/2002 | EP1228760A2 5-membered heterocycle derivatives, production thereof and use thereof as medicaments |
| 08/07/2002 | EP1228224A1 Recombinant attenuated listerias for immunotherapy |
| 08/07/2002 | EP1228222A2 Human transferase molecules |
| 08/07/2002 | EP1228221A2 Human sphingosine kinase gene |
| 08/07/2002 | EP1228212A2 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
| 08/07/2002 | EP1228203A2 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
| 08/07/2002 | EP1228147A1 Dye labeled imidazoquinoline compounds |
| 08/07/2002 | EP1228095A1 Modified gp100 and uses thereof |
| 08/07/2002 | EP1228092A1 24 human secreted proteins |
| 08/07/2002 | EP1228088A2 Novel traf family proteins |
| 08/07/2002 | EP1228082A1 29 human secreted proteins |
| 08/07/2002 | EP1228076A1 A substantially cell membrane impermeable compound and use thereof |
| 08/07/2002 | EP1228073A2 Imidazole compounds used as phosphodiesterase vii inhibitors |
| 08/07/2002 | EP1228072A1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
| 08/07/2002 | EP1228071A1 Pharmaceutically active isoindoline derivatives |
| 08/07/2002 | EP1228070A1 Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase |
| 08/07/2002 | EP1228067A1 5-membered n-heterocyclic compounds with hypogylcemic and hypolipidemic activity |
| 08/07/2002 | EP1228060A1 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof |
| 08/07/2002 | EP1228059A1 Novel cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof |
| 08/07/2002 | EP1228055A1 Dihydroaminobenzo[b]- and [c]furans as retinoid-like agents |
| 08/07/2002 | EP1228054A1 Compounds and their use as cysteine protease inhibitors |
| 08/07/2002 | EP1228047A1 Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate and use thereof as endothelin antagonist |
| 08/07/2002 | EP1228046A1 Phthalazinone derivatives as pde 4 inhibitors |
| 08/07/2002 | EP1228042A2 Tetrahydroquinoline derivatives having retinoid-like biological activity |
| 08/07/2002 | EP1228037A1 Compounds having mif antagonist activity |
| 08/07/2002 | EP1228024A1 Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 08/07/2002 | EP1227847A2 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy |
| 08/07/2002 | EP1227840A1 Adjuvanted genetic vaccines |
| 08/07/2002 | EP1227838A2 Melanoma vaccine and methods of making and using same |
| 08/07/2002 | EP1227837A1 Method of inducing and/or enhancing an immune response to tumor antigens |
| 08/07/2002 | EP1227833A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 08/07/2002 | EP1227826A2 Composition comprising an extract of perna canaliculus, methylsulfonylmethane and glucosamine |
| 08/07/2002 | EP1227822A2 Methods for restoring or enhancing t-cell immune surveillance following naturally or artifically induced immunosuppression |
| 08/07/2002 | EP1227813A1 Reverse-turn mimetics and methods relating thereto |
| 08/07/2002 | EP1227811A2 Use of 2-imidazolyl substituted carbinols for production of a medicament for treatment or prophylaxis of disease states as a result of ischaemic conditions |
| 08/07/2002 | EP1227808A2 Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation |
| 08/07/2002 | EP1227791A2 Use of aromatic polycyclic compounds as activators of ppars-type receptors in a cosmetic or pharmaceutical composition |
| 08/07/2002 | EP0906276B1 Novel vitamin d analogues |
| 08/07/2002 | EP0888336B1 Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl-amino)p iperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases |
| 08/07/2002 | EP0874843B1 Substituted 4-(1h-benzimidazol-2-yl) 1,4]diazepanes useful for the treatment of allergic diseases |
| 08/07/2002 | EP0801649B1 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof |
| 08/07/2002 | EP0701434B1 Preparations containing silicon dioxide to improve the taste thereof |
| 08/07/2002 | CN1362953A Pyrazole compositions useful as inhibitors of ERK |
| 08/07/2002 | CN1362947A N-cyanomethylamides as protease inhibitors |
| 08/07/2002 | CN1362880A Immunomodulating polymers |
| 08/07/2002 | CN1362262A Beaver thymosin injection and its prepn |
| 08/07/2002 | CN1362261A Health tonic containing rich lucid ganoderma selenium |
| 08/07/2002 | CN1362246A Nano Bupleuric medicine for regulating Shaoyang and it spreparation |
| 08/07/2002 | CN1362229A Nano Maiwei Rehmannine Praeparatae medicine and its preparation |
| 08/07/2002 | CN1362225A Nano medicine of four mild ingredients and its preparation |
| 08/07/2002 | CN1362215A Nano Ginseng, poria and Atractylodis medicine and its preparation |
| 08/07/2002 | CN1362212A Nano mixed heartleaf houttuynia herb medicine and its preparation |
| 08/07/2002 | CN1362208A Nano astragalus medicine and its preparation |
| 08/07/2002 | CN1362201A Nano Ankunzanyu medicine and its preparation |
| 08/07/2002 | CN1362186A Nano manyprickle acanthopanax root medicine and its preparation |
| 08/07/2002 | CN1362182A Nano spleen-invigorating medicine and its preparation |
| 08/07/2002 | CN1362174A Nano stomach nourishing Yangweishu medicine and its preparation |
| 08/07/2002 | CN1362166A Nano four-drug medicine and its preparation |
| 08/07/2002 | CN1362165A Nano spirulina medicine and its preparation |
| 08/07/2002 | CN1362160A Nano Heavn king tonic medicine for mental discomfort and its preparation |
| 08/07/2002 | CN1362139A Nano Pingxiao medicine and its preparation |
| 08/07/2002 | CN1362112A Nano menorrhagia treating Gujing medicine and its preparation |
| 08/07/2002 | CN1362109A Nano chanfukang medicine for postnatal restoration and its preparation |
| 08/07/2002 | CN1362068A Rheumatoid disease treating capsule |
| 08/07/2002 | CN1362061A New medicine use of 6-methoxy-2-delta 10'-cis-heptadecene-1,4 benzoquinone |
| 08/07/2002 | CN1362023A Vitality invigorating anticancer cracker |
| 08/07/2002 | CN1088721C Interferon conjugates |
| 08/07/2002 | CN1088710C Water soluble repamycin esters |
| 08/07/2002 | CA2369202A1 Live vaccines for allergy treatment |
| 08/06/2002 | US6429303 Nucleic acids encoding members of the human B lymphocyte activation antigen B7 family and methods of using the same |
| 08/06/2002 | US6429287 Tumor rejection antigens; cancer diagnosis; activators of cytolysis |
| 08/06/2002 | US6429223 Modified forms of pharmacologically active agents and uses therefor |
| 08/06/2002 | US6429221 Inhibitors of tumor necrosis factor; used to treat cachexia, endotoxic shock, and retrovirus replication |
| 08/06/2002 | US6429213 Cyclic hydroxamic acids as metalloproteinase inhibitors |
| 08/06/2002 | US6429199 Immunostimulatory nucleic acid molecules for activating dendritic cells |
| 08/06/2002 | US6429188 Vasoactive intestinal peptide and peptide activating hypofissiary adenylate cyclase; inhibiting production of tumor necrosis factor and interleukin 6; amino acid seq id no:1, 2 and 3 |
| 08/06/2002 | US6428970 Chemokine inhibition of immunodeficiency virus |
| 08/06/2002 | US6428807 Matrix of saponin preparation, a sterol, a phospholipid and a metal chelating moeity that can bind a protein or polypeptide |
| 08/06/2002 | US6428782 Non-myeloablative tolerogenic treatment |
| 08/06/2002 | CA2122714C Materials comprising and methods of preparation and use for ribosome-inactivating proteins |
| 08/06/2002 | CA2076060C Compounds named the adenophostins, their preparation and their therapeutic use |
| 08/06/2002 | CA2057010C Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof |
| 08/01/2002 | WO2002059323A2 Aminoacyl trna synthetases |
| 08/01/2002 | WO2002059308A2 Method of diagnosing and treating cartilage disorders |
| 08/01/2002 | WO2002059304A1 Novel g protein-coupled receptor protein and dna thereof |
| 08/01/2002 | WO2002059295A1 Novel serine protease mp493 |
| 08/01/2002 | WO2002059286A2 Adenylate cyclases |
| 08/01/2002 | WO2002059283A2 Nucleic acid modification enzymes |
| 08/01/2002 | WO2002059267A2 Constitutively desensitized g protein-coupled receptors |
| 08/01/2002 | WO2002059154A2 Neutralizing human monoclonal antibodies against hiv-1, their production and uses |
| 08/01/2002 | WO2002059146A2 Peptides having affinity for the gp120 viral protein and use thereof |
| 08/01/2002 | WO2002059131A1 Formulation of boronic acid compounds |
| 08/01/2002 | WO2002059130A1 Formulation of boronic acid compounds |
| 08/01/2002 | WO2002059114A1 Lfa-1 antagonist compounds |